PEGylated polylysine dendrimers increase lymphatic exposure to doxorubicin when compared to PEGylated liposomal and solution formulations of doxorubicin

Gemma M. Ryan, Lisa M. Kaminskas, Jürgen B. Bulitta, Michelle P. McIntosh, David J. Owen, Christopher J. H. Porter

Journal of Controlled Release · 2013 · 84 citations · 30 references

Concepts

References

30